Tech Company Financing Transactions
Alveo Technologies Funding Round
Maxim Group and private investors joined a $38 million Series A funding round for Alveo Technologies. The round was announced on 1/9/2018.
Transaction Overview
Company Name
Announced On
1/9/2018
Transaction Type
Venture Equity
Amount
$38,000,000
Round
Series A
Investors
Proceeds Purpose
The offering proceeds will be used to advance the optimization and commercialization of Alveo's rapid diagnostic platform for infectious diseases.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1000 Atlantic Ave. 114
Alameda, CA 94501
USA
Alameda, CA 94501
USA
Phone
Website
Email Address
Overview
Alveo Technologies is changing the world by applying cutting edge advances in sensing, microfluidics, and bioassays to create the next-generation of disease and personal care diagnostic devices.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Lawrence Blatt
Chairman
Isaac Blech
Chief Executive Officer
Ronald Chiarello
Chief Technical Officer
Johnson Chiang
Founder
Sumita Pennathur
President
Michael Aicher
VP - Engineering
Kyle Montgomery
VP - Operations
Brenna Lord
Browse more venture capital transactions:
Prev: 1/9/2018: Leading Pharma venture capital transaction
Next: 1/9/2018: Collibra venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs